# Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia

> **NCT02245529** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 982 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT02245529
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-09
- **Final completion:** —
- **Target enrollment:** 982 (ACTUAL)
- **Last updated:** 2014-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02245529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02245529, "Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02245529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*